76.24 USD
+0.11 (+0.14%)
We assign a fundamental rating of 4 out of 10 to HSIC. HSIC was compared to 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of HSIC while its profitability can be described as average. HSIC has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
HSIC had positive earnings in the past year.
In the past year HSIC had a positive cash flow from operations.
Each year in the past 5 years HSIC has been profitable.
In the past 5 years HSIC always reported a positive cash flow from operatings.
1.2 Ratios
HSIC has a better Return On Assets (3.52%) than 65.35% of its industry peers.
HSIC has a Return On Equity of 11.63%. This is in the better half of the industry: HSIC outperforms 75.25% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.64%, HSIC is in the better half of the industry, outperforming 64.36% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for HSIC is in line with the industry average of 9.58%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.52% | ||
| ROE | 11.63% | ||
| ROIC | 6.64% |
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
1.3 Margins
HSIC has a Profit Margin of 3.02%. This is in the better half of the industry: HSIC outperforms 66.34% of its industry peers.
In the last couple of years the Profit Margin of HSIC has declined.
The Operating Margin of HSIC (5.94%) is better than 63.37% of its industry peers.
In the last couple of years the Operating Margin of HSIC has declined.
HSIC's Gross Margin of 31.19% is in line compared to the rest of the industry. HSIC outperforms 58.42% of its industry peers.
In the last couple of years the Gross Margin of HSIC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.94% | ||
| PM (TTM) | 3.02% | ||
| GM | 31.19% |
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
2. Health
2.1 Basic Checks
HSIC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
HSIC has less shares outstanding than it did 1 year ago.
The number of shares outstanding for HSIC has been reduced compared to 5 years ago.
Compared to 1 year ago, HSIC has a worse debt to assets ratio.
2.2 Solvency
HSIC has an Altman-Z score of 2.65. This is not the best score and indicates that HSIC is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.65, HSIC is in line with its industry, outperforming 55.45% of the companies in the same industry.
HSIC has a debt to FCF ratio of 8.70. This is a slightly negative value and a sign of low solvency as HSIC would need 8.70 years to pay back of all of its debts.
With a Debt to FCF ratio value of 8.70, HSIC perfoms like the industry average, outperforming 50.49% of the companies in the same industry.
HSIC has a Debt/Equity ratio of 0.91. This is a neutral value indicating HSIC is somewhat dependend on debt financing.
HSIC has a Debt to Equity ratio (0.91) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 8.7 | ||
| Altman-Z | 2.65 |
ROIC/WACC0.76
WACC8.72%
2.3 Liquidity
HSIC has a Current Ratio of 1.40. This is a normal value and indicates that HSIC is financially healthy and should not expect problems in meeting its short term obligations.
HSIC has a Current ratio (1.40) which is in line with its industry peers.
HSIC has a Quick Ratio of 1.40. This is a bad value and indicates that HSIC is not financially healthy enough and could expect problems in meeting its short term obligations.
HSIC has a Quick ratio of 0.79. This is in the lower half of the industry: HSIC underperforms 77.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.4 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 14.49% over the past year.
HSIC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.19% yearly.
Looking at the last year, HSIC shows a small growth in Revenue. The Revenue has grown by 3.51% in the last year.
Measured over the past years, HSIC shows a small growth in Revenue. The Revenue has been growing by 4.88% on average per year.
EPS 1Y (TTM)14.49%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%13.11%
Revenue 1Y (TTM)3.51%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%5.2%
3.2 Future
Based on estimates for the next years, HSIC will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.14% on average per year.
Based on estimates for the next years, HSIC will show a small growth in Revenue. The Revenue will grow by 3.28% on average per year.
EPS Next Y5.85%
EPS Next 2Y6.73%
EPS Next 3Y7.97%
EPS Next 5Y8.14%
Revenue Next Year2.47%
Revenue Next 2Y2.91%
Revenue Next 3Y3.2%
Revenue Next 5Y3.28%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 15.82, which indicates a correct valuation of HSIC.
Based on the Price/Earnings ratio, HSIC is valued cheaper than 80.20% of the companies in the same industry.
When comparing the Price/Earnings ratio of HSIC to the average of the S&P500 Index (26.92), we can say HSIC is valued slightly cheaper.
The Price/Forward Earnings ratio is 14.12, which indicates a correct valuation of HSIC.
80.20% of the companies in the same industry are more expensive than HSIC, based on the Price/Forward Earnings ratio.
HSIC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.82 | ||
| Fwd PE | 14.12 |
4.2 Price Multiples
HSIC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HSIC is cheaper than 70.30% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as HSIC.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.21 | ||
| EV/EBITDA | 10.25 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
HSIC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.7
PEG (5Y)2.55
EPS Next 2Y6.73%
EPS Next 3Y7.97%
5. Dividend
5.1 Amount
HSIC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:HSIC (12/29/2025, 11:12:15 AM)
76.24
+0.11 (+0.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners97.3%
Inst Owner Change-5%
Ins Owners0.79%
Ins Owner Change-0.29%
Market Cap8.97B
Revenue(TTM)12.94B
Net Income(TTM)391.00M
Analysts71.82
Price Target79.3 (4.01%)
Short Float %6.45%
Short Ratio4.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.88%
Min EPS beat(2)-9.54%
Max EPS beat(2)5.78%
EPS beat(4)2
Avg EPS beat(4)-1.38%
Min EPS beat(4)-9.54%
Max EPS beat(4)5.78%
EPS beat(8)4
Avg EPS beat(8)-0.56%
EPS beat(12)5
Avg EPS beat(12)-0.94%
EPS beat(16)7
Avg EPS beat(16)0.24%
Revenue beat(2)0
Avg Revenue beat(2)-0.76%
Min Revenue beat(2)-1.43%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-2.59%
Min Revenue beat(4)-5.06%
Max Revenue beat(4)-0.09%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)0
Avg Revenue beat(12)-3.01%
Revenue beat(16)1
Avg Revenue beat(16)-2.68%
PT rev (1m)0.75%
PT rev (3m)5.84%
EPS NQ rev (1m)0.11%
EPS NQ rev (3m)-0.24%
EPS NY rev (1m)2.01%
EPS NY rev (3m)2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.68%
Revenue NY rev (1m)0.72%
Revenue NY rev (3m)0.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.82 | ||
| Fwd PE | 14.12 | ||
| P/S | 0.69 | ||
| P/FCF | 25.21 | ||
| P/OCF | 16.78 | ||
| P/B | 2.67 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.25 |
EPS(TTM)4.82
EY6.32%
EPS(NY)5.4
Fwd EY7.08%
FCF(TTM)3.02
FCFY3.97%
OCF(TTM)4.54
OCFY5.96%
SpS109.9
BVpS28.55
TBVpS-15.56
PEG (NY)2.7
PEG (5Y)2.55
Graham Number55.64
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.52% | ||
| ROE | 11.63% | ||
| ROCE | 9.68% | ||
| ROIC | 6.64% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 16.65% | ||
| OM | 5.94% | ||
| PM (TTM) | 3.02% | ||
| GM | 31.19% | ||
| FCFM | 2.75% |
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
ROICexc(3y)8.17%
ROICexc(5y)8.74%
ROICexgc(3y)19.66%
ROICexgc(5y)20.9%
ROCE(3y)10.93%
ROCE(5y)11.41%
ROICexgc growth 3Y-9.94%
ROICexgc growth 5Y-7.93%
ROICexc growth 3Y-12.98%
ROICexc growth 5Y-8.63%
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
F-Score5
Asset Turnover1.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 8.7 | ||
| Debt/EBITDA | 2.85 | ||
| Cap/Depr | 58.69% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 5.16 | ||
| Cash Conversion | 49.81% | ||
| Profit Quality | 91.05% | ||
| Current Ratio | 1.4 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 2.65 |
F-Score5
WACC8.72%
ROIC/WACC0.76
Cap/Depr(3y)61.22%
Cap/Depr(5y)49.53%
Cap/Sales(3y)1.25%
Cap/Sales(5y)0.97%
Profit Quality(3y)112.93%
Profit Quality(5y)114.98%
High Growth Momentum
Growth
EPS 1Y (TTM)14.49%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%13.11%
EPS Next Y5.85%
EPS Next 2Y6.73%
EPS Next 3Y7.97%
EPS Next 5Y8.14%
Revenue 1Y (TTM)3.51%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%5.2%
Revenue Next Year2.47%
Revenue Next 2Y2.91%
Revenue Next 3Y3.2%
Revenue Next 5Y3.28%
EBIT growth 1Y26.48%
EBIT growth 3Y-5.01%
EBIT growth 5Y0.11%
EBIT Next Year15.49%
EBIT Next 3Y8.36%
EBIT Next 5Y7.01%
FCF growth 1Y-45.15%
FCF growth 3Y1.58%
FCF growth 5Y1.99%
OCF growth 1Y-31.93%
OCF growth 3Y6.12%
OCF growth 5Y4.66%
HENRY SCHEIN INC / HSIC FAQ
Can you provide the ChartMill fundamental rating for HENRY SCHEIN INC?
ChartMill assigns a fundamental rating of 4 / 10 to HSIC.
Can you provide the valuation status for HENRY SCHEIN INC?
ChartMill assigns a valuation rating of 5 / 10 to HENRY SCHEIN INC (HSIC). This can be considered as Fairly Valued.
Can you provide the profitability details for HENRY SCHEIN INC?
HENRY SCHEIN INC (HSIC) has a profitability rating of 6 / 10.
What is the earnings growth outlook for HENRY SCHEIN INC?
The Earnings per Share (EPS) of HENRY SCHEIN INC (HSIC) is expected to grow by 5.85% in the next year.